Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · Real-Time Price · USD
89.87
+6.60 (7.93%)
At close: Nov 21, 2025, 4:00 PM EST
90.45
+0.58 (0.65%)
After-hours: Nov 21, 2025, 7:56 PM EST

Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.

The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.

It also develops a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway.

The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Inspire Medical Systems, Inc.
Inspire Medical Systems logo
CountryUnited States
Founded2007
IPO DateMay 3, 2018
IndustryMedical Devices
SectorHealthcare
Employees1,246
CEOTimothy Herbert

Contact Details

Address:
5500 Wayzata Blvd., Suite 1600
Golden Valley, Minnesota 55416
United States
Phone(844) 672-4357
Websiteinspiresleep.com

Stock Details

Ticker SymbolINSP
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001609550
CUSIP Number457730109
ISIN NumberUS4577301090
Employer ID26-1377674
SIC Code3841

Key Executives

NamePosition
Timothy P. HerbertFounder, Chairman, Chief Executive Officer and President
Richard J. BuchholzChief Financial Officer
Bryan K. Phillips J.D.Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
Randall A. BanExecutive Vice President of Patient Access &Therapy Development
Carlton W. WeatherbyChief Strategy and Growth Officer
Jason P. KellyChief Operations and Quality Officer
Ezgi YagciVice President of Investor Relations
Melissa J. MannChief People Officer
John C. RondoniChief Product and Innovation Officer
Ivan LubogoSVice President of Strategic Sales

Latest SEC Filings

DateTypeTitle
Nov 17, 20258-KCurrent Report
Nov 14, 2025SCHEDULE 13G/AFiling
Nov 13, 2025SCHEDULE 13GFiling
Nov 12, 2025SCHEDULE 13G/AFiling
Nov 3, 202510-QQuarterly Report
Nov 3, 20258-KCurrent Report
Oct 17, 2025SCHEDULE 13G/AFiling
Oct 10, 20258-KCurrent Report
Oct 7, 2025SCHEDULE 13G/AFiling
Oct 6, 2025SCHEDULE 13GFiling